Peripheral blood inflammatory cytokines are associated with rapid eye movement sleep behavior disorder in Parkinson's disease

被引:10
作者
Wang, Lan-xiang
Liu, Chang
Shao, Ying-qi
Jin, Hong
Mao, Cheng-jie
Chen, Jing [1 ]
机构
[1] Soochow Univ, Dept Neurol, Affiliated Hosp 2, Suzhou 215004, Jiangsu, Peoples R China
关键词
Peripheral inflammation; REM sleep behavior disorder; Cognition; Parkinson?s disease; CLINICAL DIAGNOSTIC-CRITERIA; RISK; DEMENTIA; BRAIN;
D O I
10.1016/j.neulet.2022.136692
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: Previous studies have shown the essential role of inflammation in rapid eye movement (REM) sleep behavior disorder (RBD). However, the association of RBD in Parkinson's disease (PD) with peripheral blood inflammatory cytokines is still unknown. We investigated the relationship between inflammatory cytokines and the clinical characteristics of PD patients with RBD.Methods: A total of 153 PD patients and 36 healthy controls were included in this study, and blood plasma was collected. PD patients were classified as PD with RBD (PD-RBD, n = 60) and PD without RBD (PD-nRBD, n = 93). Inflammatory factor levels were compared among the control, PD-RBD, and PD-nRBD groups.Results: The PD-RBD group had significantly higher C-reactive protein (CRP) levels (P < 0.001), monocytes (P = 0.003), and neutrophil-to-lymphocyte ratio (NLR) (P < 0.001), whereas this group has lower lymphocytes levels (P < 0.001) and lymphocyte-to-monocyte ratio (LMR) (P < 0.001) than the PD-nRBD group. Univariate and multivariate logistic regression analysis indicated that LMR (P < 0.0001 odds ratio [OR] = 0.424) was a pro-tective factor, whereas CRP (P < 0.001 OR = 2.326) was a risk factor for the PD-RBD group. PD-RBD patients had lower Montreal Cognitive Assessment (Beijing version) (MoCA) (P < 0.001) and Mini-Mental State Examination (MMSE) (P = 0.039) scores than PD-nRBD patients.Conclusions: Significant differences were found in inflammation levels between PD-RBD and PD-nRBD, suggesting that inflammatory factors are associated with the pathogenesis of RBD in PD patients. Thus, CRP and LMR levels may serve as biomarkers and predict the prognosis of PD patients with RBD.
引用
收藏
页数:6
相关论文
共 39 条
[1]   To sleep, perchance to dement: RBD and cognitive decline in Parkinson's disease [J].
Burn, David J. ;
Anderson, Kirstie .
MOVEMENT DISORDERS, 2012, 27 (06) :671-673
[2]   Alcohol and NREM Parasomnias: Evidence versus Opinions in the International Classification of Sleep Disorders, 3rd Edition [J].
Cartwright, Rosalind D. .
JOURNAL OF CLINICAL SLEEP MEDICINE, 2014, 10 (09) :1039-1040
[3]   CRP-induced levels of oxidative stress are higher in brain than aortic endothelial cells [J].
Closhen, Dorothea ;
Bender, Bianca ;
Luhmann, Heiko J. ;
Kuhlmann, Christoph R. W. .
CYTOKINE, 2010, 50 (02) :117-120
[4]   REM sleep behaviour disorder [J].
Dauvilliers, Yves ;
Schenck, Carlos H. ;
Postuma, Ronald B. ;
Iranzo, Alex ;
Luppi, Pierre-Herve ;
Plazzi, Giuseppe ;
Montplaisir, Jacques ;
Boeve, Bradley .
NATURE REVIEWS DISEASE PRIMERS, 2018, 4
[5]   The Role of α-Synuclein Oligomers in Parkinson's Disease [J].
Du, Xiao-yu ;
Xie, Xi-xiu ;
Liu, Rui-tian .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) :1-17
[6]   Clinical diagnostic criteria for dementia associated with Parkinson's disease [J].
Emre, Murat ;
Aarsland, Dag ;
Brown, Richard ;
Bum, David J. ;
Duyckaerts, Charles ;
Mizuno, Yoshikino ;
Broe, Gerald Anthony ;
Cummings, Jeffrey ;
Dickson, Dennis W. ;
Gauthier, Serge ;
Goldman, Jennifer ;
Goetz, Christopher ;
Korczyn, Amos ;
Lees, Andrew ;
Levy, Richard ;
Litvan, Irene ;
McKeith, Ian ;
Olanow, Warren ;
Poewe, Werner ;
Quinn, Niall ;
Sampaio, Christina ;
Tolosa, Eduardo ;
Dubois, Bruno .
MOVEMENT DISORDERS, 2007, 22 (12) :1689-1707
[7]   Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts [J].
Fellner, Lisa ;
Jellinger, Kurt A. ;
Wenning, Gregor K. ;
Stefanova, Nadia .
ACTA NEUROPATHOLOGICA, 2011, 121 (06) :675-693
[8]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[9]   Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis [J].
Gagne, Joshua J. ;
Power, Melinda C. .
NEUROLOGY, 2010, 74 (12) :995-1002
[10]   Neuroinflammation in Parkinson's disease: a target for neuroprotection? [J].
Hirsch, Etienne C. ;
Hunot, Stephane .
LANCET NEUROLOGY, 2009, 8 (04) :382-397